CROMA PhilArt Next 1x2 ml – Hybrid Polynucleotide & Hyaluronic Acid Biostimulator for Facial Rejuvenation
 
CROMA PhilArt Next 1x2 ml is an advanced injectable biostimulator combining high-purity polynucleotides (PN-HPT™) with non-crosslinked hyaluronic acid to deliver comprehensive skin rejuvenation and hydration.
This hybrid formula is specifically developed to revitalize mature or fatigued skin, improving elasticity, density, and radiance while stimulating fibroblast activity for long-term collagen production.
Unlike volumizing fillers, PhilArt Next acts biologically, repairing the dermal matrix, restoring hydration, and reinforcing skin structure from within for smoother, healthier, and more luminous skin.
 
Product Overview
PhilArt Next represents Croma-Pharma’s new generation of hybrid biostimulators, merging hydrating hyaluronic acid with regenerative polynucleotides (PN-HPT™) for synergistic rejuvenation.
It is designed for patients who show visible signs of aging such as fine lines, dehydration, dullness, and loss of elasticity, offering progressive, natural improvement without altering facial contours.
 
Technology & Composition
Technology:
• PN-HPT™ (Polynucleotides Highly Purified Technology) – stimulates fibroblasts, collagen synthesis, and dermal repair.
• Non-Crosslinked Hyaluronic Acid – restores hydration, turgor, and elasticity.
Composition:
• Polynucleotides (high purity)
• Non-crosslinked Hyaluronic Acid (HA)
• Buffer solution maintaining isotonic and physiological pH
Packaging (Content):
• 1 sterile vial of 2 ml
• Instruction leaflet and professional labeling
• Single-patient use only
 
Indications & Treatment Areas
Facial rejuvenation and overall skin quality improvement
Loss of elasticity and firmness
Fine lines and dehydration
Dull or tired skin needing radiance restoration
Pre- or post-procedure dermal recovery
 
Recommended Areas:
Face (cheeks, temples, forehead), neck, and décolleté.
 
Clinical Benefits
Dual-action formula: hydration + bioregeneration
Stimulates collagen and elastin synthesis for improved firmness
Boosts dermal hydration and radiance
Enhances elasticity and tone with visible skin smoothing
Restores the extracellular matrix without volumization
Biocompatible and safe for all skin types
 
Treatment Protocol
Sessions: 3–4 sessions spaced 2–3 weeks apart
Maintenance: every 6–9 months depending on skin condition
Application: microinjections into the superficial to mid-dermis using mesotherapy or micropapule technique
Duration of results: visible improvements from the first few sessions, lasting 6–12 months depending on skin condition and lifestyle
 
Manufacturer & Regulatory Information
Manufactured by CROMA-Pharma GmbH (Austria).
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745.
ISO 13485 certified manufacturer.
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union.
 
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety and patient care.